For example, in the amyloidosis of human transthyretin, the sequence-dependent unfolding pathway in these mutants may lead to the production of amyloidogenic intermediates, even though only minor structural differences between WT and disease-associated mutant proteins were found [33]. Here, TTR is linked to amyloidosis.